Bhagyalakshmi Nair

Amrita Institute of Medical Sciences and Research Centre

Publishes on Liver Disease Diagnosis and Treatment, Hepatocellular Carcinoma Treatment and Prognosis, SARS-CoV-2 and COVID-19 Research. 45 papers and 798 citations.

PubIndex Score23Top 77% · mid-careerHow it's scored

45Publications

798Total Citations

First publication: 2018First senior author: 2020

Liver Disease Diagnosis and Treatment Hepatocellular Carcinoma Treatment and Prognosis SARS-CoV-2 and COVID-19 Research Glycosylation and Glycoproteins Research Phytochemicals and Medicinal Plants

Top publicationsby citations

Harnessing the immune system against cancer: current immunotherapy approaches and therapeutic targets

Ayana R. Kumar, Lekshmi R. Nath, Aswathy R. Devan et al.|Molecular Biology Reports|2021

Cited by 148

Inevitable role of TGF-β1 in progression of nonalcoholic fatty liver disease

Bhagyalakshmi Nair, Lekshmi R. Nath|Journal of Receptors and Signal Transduction|2020

Cited by 74

Cogent role of flavonoids as key orchestrators of chemoprevention of hepatocellular carcinoma: A review

Jasmine Baby, Lekshmi R. Nath, Aswathy R. Devan et al.|Journal of Food Biochemistry|2021

Cited by 50

The role of glypican-3 in hepatocellular carcinoma: Insights into diagnosis and therapeutic potential

Aswathy R. Devan, Javad Sharifi‐Rad, Bhagyalakshmi Nair et al.|European journal of medical research|2024

Cited by 40

Deciphering the role of transforming growth factor-beta 1 as a diagnostic-prognostic-therapeutic candidate against hepatocellular carcinoma

Aswathy R. Devan, Lekshmi R. Nath, K Pavithran et al.|World Journal of Gastroenterology|2022

Cited by 37